Sleep disorder market Share, Size, Trends, & Industry Analysis Report 2019-2026
Product Code: RP-ID-10322071 |
Published Date: 21 Oct 2022 |
Region: Global |
Category: ICT & Telecom |
Report ID: 10322071
Market Overview:
Sleep disorder market Share, Size, Trends, & Industry Analysis Report 2019-2026
Sleep Disorders is a condition that affects the ability to sleep well on a regular basis, which is caused by a health problem by much stress. Similarly, it can be occasionally experience sleeping problems due to hectic schedules, stress, and another outsider influence. Sleep disorder can lead to further lead to further health consequences. This disorder is characterized by difficulty in falling asleep, daytime fatigue, lack of concentration, anxiety, and depression.
This disorder may cause severe health issues such as allergies and respiratory problem, chronic pain, nocturia, and stress & anxiety. The frequency of sleep disorders has been expressively increasing over the years, which is estimated to be the key factor driving the market growth. According to an industry report, approximately 75% population in the United States that are between 20 and 60 years old have frequent sleeping difficulties.
Asia Pacific was observed to be the fastest growing region in the market in terms of revenue. APAC has high number of people suffering from sleeping disorder. Thus, increasing demand for effective treatment is expected to provide lucrative growth opportunity in the region. Additionally, increasing awareness about sleep disorders, developing healthcare infrastructure, and changing lifestyle preferences of the population are some of the other factors anticipated to provide robust growth opportunities for the market during the forecast period.
Sleep Disorder Market Major Key Players are mentioned in this Report:
GlaxoSmithKline plc
Becton Dickson and Company
Cardinal Health
Natus Medical Incorporated
Takeda Pharmaceutical Company Limited
Koninklijke Philips N.V.
Teva Pharmaceutical Industries Ltd
By Segmentation
By Disorder:
-Insomnia
-Hypersomnia
-Insufficient Sleep Syndrome
-Narcolepsy
-Sleep Apnea
-Sleep Breathing Disorders
-Circadian Rhythm Disorders
-Sleep Movement Disorders
-Restless Leg Syndrome
-Sleep Leg Cramps
By Devices:
-Sleep Apnea Devices
-Sleep Laboratories
-Mattresses & Pillows
By Treatment :
-Psychiatric Treatment
-Behavioral Treatment
-Cognitive Behavioral Therapy
-Medication Therapy
-Prescription Drugs
-OTC Drugs
-Herbal Drugs
By Regional Ananlysis
North America
*U.S.
*Canada
Europe
*Germany
*UK
*France
*Italy
*Spain
*Belgium
*Russia
*Netherlands
*Rest of Europe
Asia-Pacific
*China
*India
*Japan
*Korea
*Singapore
*Malaysia
*Indonesia
*Thailand
*Philippines
*Rest of Asia-Pacific
Latin America
*Brazil
*Mexico
*Argentina
*Rest of LATAM
Middle East & Africa
*UAE
*Saudi Arabia
*South Africa
*Rest of MEA
Related Reports
Study Period : 2023-2035
Report Format : PDF,PPT
Delivery Timeline : 48-72 Business Hours
Proof of Quality & Reliability
